Interestingly, a recent study by [37] has showed that the expression of serum response factor (SRF) promotes the stemness of basal-like type breast cancers by activating Interleukin 6 (IL6) through binding to the Yes-associated protein (YAP). This evidence concerns the gene IL6 and breast cancer.